1Wazana A. Physicians and the pharmaceutical industry. JAMA 2000; 283 : 373.
2GriffithD. Reasons for not seeing drug representatives. BMJ 1999; 319: 69.
3Benseman J: The great paper waste: the use of unsolicited med - ical literature by general practitioners. N Z Facin Physiciain 1985:12: 96.
4Greenwood J: Phliarmllaceluticail Representatives and the Prescrih - ing of Drug. s by Fanmily Doctors (doctoral thesis). Nottingham U. Nottingham, England, 1989.
5Bower AD, Burkett GL: Family physicians and generic drugs: astudy of recognition, information sources, prescribing attitudes, and practices. J Faini Pract 1987; 24: 612.
6Shin JH, Haynes RB, Johnston ME: Effect of problem - based, self - directed under- graduate education on life-long learning. Can MedAssoc J 1993 ; 148 : 969.
7Taylor RJ, Bond CM: Change in the estab- lished prescribing habits of general practitioners: an analysis of initial prescriptions in general practice. BrJ Gemi Pract 1991; 41: 244.
8Blumenthal D. Doctors and drug companies. N Engl J Med 2004; 351 : 1885.
9AngellM. The Truth About Drug Companies. New York, NY: Random House ; 2004.
10KerberR. Drug makers target consumers with their ads. Boston Globe. March 10, 2004 :C1.
